|
Volumn 87, Issue 3, 2001, Pages 279-284
|
Recombinant hCG (OVIDREL™) and recombinant Interferon-β1a (REBIF®) (No. 13 in a series of articles to promote a better understanding of the use of genetic engineering)
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA1A INTERFERON;
CHORIONIC GONADOTROPIN;
RECOMBINANT CHORIONIC GONADOTROPIN;
GENETIC ENGINEERING;
GENOME;
HUMAN;
INFERTILITY;
MULTIPLE SCLEROSIS;
OVULATION;
PRIORITY JOURNAL;
RECURRENT DISEASE;
REVIEW;
ANIMALS;
CHO CELLS;
CHORIONIC GONADOTROPIN;
CLINICAL TRIALS;
CRICETINAE;
FEMALE;
HUMANS;
INFERTILITY, FEMALE;
PROTEIN ENGINEERING;
RECOMBINANT PROTEINS;
|
EID: 0035907154
PISSN: 01681656
EISSN: None
Source Type: Journal
DOI: 10.1016/S0168-1656(01)00238-3 Document Type: Review |
Times cited : (6)
|
References (0)
|